BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 11279127)

  • 1. Identification of novel TGF-beta /Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach.
    Verrecchia F; Chu ML; Mauviel A
    J Biol Chem; 2001 May; 276(20):17058-62. PubMed ID: 11279127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
    Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
    J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad-dependent stimulation of type I collagen gene expression in human skin fibroblasts by TGF-beta involves functional cooperation with p300/CBP transcriptional coactivators.
    Ghosh AK; Yuan W; Mori Y; Varga J
    Oncogene; 2000 Jul; 19(31):3546-55. PubMed ID: 10918613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-beta repression of matrix metalloproteinase-1 in dermal fibroblasts involves Smad3.
    Yuan W; Varga J
    J Biol Chem; 2001 Oct; 276(42):38502-10. PubMed ID: 11502752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor suppressor p53 abrogates Smad-dependent collagen gene induction in mesenchymal cells.
    Ghosh AK; Bhattacharyya S; Varga J
    J Biol Chem; 2004 Nov; 279(46):47455-63. PubMed ID: 15345715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta.
    Mori Y; Chen SJ; Varga J
    Exp Cell Res; 2000 Aug; 258(2):374-83. PubMed ID: 10896788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of type I collagen transcription in human skin fibroblasts by TGF-beta: involvement of Smad 3.
    Chen SJ; Yuan W; Mori Y; Levenson A; Trojanowska M; Varga J
    J Invest Dermatol; 1999 Jan; 112(1):49-57. PubMed ID: 9886263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of Smad3 and SRF-associated complex mediates TGF-beta1 signals to regulate SM22 transcription during myofibroblast differentiation.
    Qiu P; Feng XH; Li L
    J Mol Cell Cardiol; 2003 Dec; 35(12):1407-20. PubMed ID: 14654367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta -inducible independent binding of SMAD to the Smad7 promoter.
    Denissova NG; Pouponnot C; Long J; He D; Liu F
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6397-402. PubMed ID: 10823886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficient Smad7 expression: a putative molecular defect in scleroderma.
    Dong C; Zhu S; Wang T; Yoon W; Li Z; Alvarez RJ; ten Dijke P; White B; Wigley FM; Goldschmidt-Clermont PJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3908-13. PubMed ID: 11904440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element.
    Frederick JP; Liberati NT; Waddell DS; Shi Y; Wang XF
    Mol Cell Biol; 2004 Mar; 24(6):2546-59. PubMed ID: 14993291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation.
    Verrecchia F; Pessah M; Atfi A; Mauviel A
    J Biol Chem; 2000 Sep; 275(39):30226-31. PubMed ID: 10903323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultraviolet irradiation induces Smad7 via induction of transcription factor AP-1 in human skin fibroblasts.
    Quan T; He T; Voorhees JJ; Fisher GJ
    J Biol Chem; 2005 Mar; 280(9):8079-85. PubMed ID: 15579469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
    Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
    Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling.
    Lai CF; Feng X; Nishimura R; Teitelbaum SL; Avioli LV; Ross FP; Cheng SL
    J Biol Chem; 2000 Nov; 275(46):36400-6. PubMed ID: 10964912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of p300 in TGF-beta/Smad-pathway-mediated alpha2(I) collagen expression in mouse mesangial cells.
    Kanamaru Y; Nakao A; Tanaka Y; Inagaki Y; Ushio H; Shirato I; Horikoshi S; Okumura K; Ogawa H; Tomino Y
    Nephron Exp Nephrol; 2003; 95(1):e36-42. PubMed ID: 14520013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smad3 and Smad4 mediate transcriptional activation of the human Smad7 promoter by transforming growth factor beta.
    von Gersdorff G; Susztak K; Rezvani F; Bitzer M; Liang D; Böttinger EP
    J Biol Chem; 2000 Apr; 275(15):11320-6. PubMed ID: 10753944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts.
    Piek E; Ju WJ; Heyer J; Escalante-Alcalde D; Stewart CL; Weinstein M; Deng C; Kucherlapati R; Bottinger EP; Roberts AB
    J Biol Chem; 2001 Jun; 276(23):19945-53. PubMed ID: 11262418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.